The flavonoid luteolin induces nitric oxide production and arterial relaxation

European Journal of Nutrition

Volumn 53, Issue 1, 2014, Pages 269-275

  Si, Hongwei ^a,b   Wyeth, Richard P ^c   Liu, Dongmin ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b TENNESSEE STATE UNIVERSITY   (United States)

^c EDWARD VIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

Author keywords

eNOS; Luteolin; NO; Vasorelaxation, endothelial cells

Indexed keywords

ANIMALS; AORTA; ARGININE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; HUMANS; LUTEOLIN; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHENYLEPHRINE; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; VASODILATION;

EID: 84895077320     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-013-0525-7     Document Type: Article

References (44)

1. 2+ current in cat atrial myocytes. J Physiol 567:143-157
2. Martin W, Furchgott RF, Villani GM, Jothianandan D (1986) Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor. J Pharmacol Exp Ther 237:529-538
3. Schulz E, Jansen T, Wenzel P, Daiber A, Munzel T (2008) Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid Redox Signal 10:1115-1126
4. Ribera-Casado JM (1999) Ageing and the cardiovascular system. Z Gerontol Geriatr 32:412-419
5. Miean KH, Mohamed S (2001) Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants. J Agric Food Chem 49:3106-3112
6. Ross JA, Kasum CM (2002) Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr 22:19-34
7. Manach C, Scalbert A, Morand C, Remesy C, Jimenez L (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr 79:727-747
8. Chowdhury AR, Sharma S, Mandal S, Goswami A, Mukhopadhyay S, Majumder HK (2002) Luteolin, an emerging anti-cancer flavonoid, poisons eukaryotic DNA topoisomerase I. Biochem J 366:653-661
9. Yee SB, Lee JH, Chung HY, Im KS, Bae SJ, Choi JS, Kim ND (2003) Inhibitory effects of luteolin isolated from Ixeris sonchifolia Hance on the proliferation of HepG2 human hepatocellular carcinoma cells. Arch Pharmacal Res 26:151-156
10. Lv PC, Li HQ, Xue JY, Shi L, Zhu HL (2008) Synthesis and biological evaluation of novel luteolin derivatives as antibacterial agents. Eur J Med Chem 44:908-914
11. Shimoi K, Saka N, Kaji K, Nozawa R, Kinae N (2000) Metabolic fate of luteolin and its functional activity at focal site. BioFactors (Oxford, England) 12:181-186
12. Xagorari A, Papapetropoulos A, Mauromatis A, Economou M, Fotsis T, Roussos C (2001) Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages. J Pharmacol Exp Ther 296:181-187
13. Horvathova K, Novotny L, Tothova D, Vachalkova A (2004) Determination of free radical scavenging activity of quercetin, rutin, luteolin and apigenin in H2O2-treated human ML cells K562. Neoplasma 51:395-399
14. Seelinger G, Merfort I, Schempp CM (2008) Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin. Planta Med 74:1667-1677
15. Englisch W, Beckers C, Unkauf M, Ruepp M, Zinserling V (2000) Efficacy of Artichoke dry extract in patients with hyperlipoproteinemia. Arzneimittelforschung 50:260-265
16. Gebhardt R (2002) Prevention of taurolithocholate-induced hepatic bile canalicular distortions by HPLC-characterized extracts of artichoke (Cynara scolymus) leaves. Planta Med 68:776-779
17. Zapolska-Downar D, Zapolski-Downar A, Naruszewicz M, Siennicka A, Krasnodebska B, Koldziej B (2002) Protective properties of artichoke (Cynara scolymus) against oxidative stress induced in cultured endothelial cells and monocytes. Life Sci 71:2808-2897
18. Li H, Xia N, Brausch I, Yao Y, Forstermann U (2004) Flavonoids from artichoke (Cynara scolymus L.) up-regulate endothelial-type nitric-oxide synthase gene expression in human endothelial cells. J Pharmacol Exp Ther 310:926-932
19. Rossoni G, Grande S, Galli C, Visioli F (2005) Wild artichoke prevents the age-associated loss of vasomotor function. J Agric Food Chem 53:10291-10296
20. Ko WC, Shih CM, Leu IJ, Chen TT, Chang JP (2005) Mechanisms of relaxant action of luteolin in isolated guinea pig trachea. Planta Med 71:406-411
21. Uydes-Dogan BS, Takir S, Ozdemir O, Kolak U, Topcu G, Ulubelen A (2005) The comparison of the relaxant effects of two methoxylated flavones in rat aortic rings. Vascul Pharmacol 43:220-226
22. Calderone V, Chericoni S, Martinelli C, Testai L, Nardi A, Morelli I, Breschi MC, Martinotti E (2004) Vasorelaxing effects of flavonoids: investigation on the possible involvement of potassium channels. Naunyn Schmiedebergs Arch Pharmacol 370:290-298
23. Mundy AL, Haas E, Bhattacharya I, Widmer CC, Kretz M, Hofmann-Lehmann R, Minotti R, Barton M (2007) Fat intake modifies vascular responsiveness and receptor expression of vasoconstrictors: implications for diet-induced obesity. Cardiovasc Res 73:368-375
24. Liu D, Jiang H, Grange RW (2005) Genistein activates the 3′,5′-cyclic adenosine monophosphate signaling pathway in vascular endothelial cells and protects endothelial barrier function. Endocrinology 146:1312-1320
25. Liu D, Si H, Reynolds KA, Zhen W, Jia Z, Dillon JS (2007) Dehydroepiandrosterone protects vascular endothelial cells against apoptosis through a Galphai protein-dependent activation of phosphatidylinositol 3-kinase/Akt and regulation of antiapoptotic Bcl-2 expression. Endocrinology 148:3068-3076
26. Kitamura T, Kimura K, Makondo K, Furuya DT, Suzuki M, Yoshida T, Saito M (2003) Proinsulin C-peptide increases nitric oxide production by enhancing mitogen-activated protein-kinase-dependent transcription of endothelial nitric oxide synthase in aortic endothelial cells of Wistar rats. Diabetologia 46:1698-1705
27. Liu D, Homan LL, Dillon JS (2004) Genistein acutely stimulates nitric oxide synthesis in vascular endothelial cells by a cyclic adenosine 5′-monophosphate-dependent mechanism. Endocrinology 145:5532-5539
28. 2+]i. Am J Physiol 262:H754-H762
29. Karaki H, Urakawa N, Kutsky P (1984) Potassium-induced contraction in smooth muscle. Nihon Heikatsukin Gakkai Zasshi 20:427-444
30. Peach MJ (1977) Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev 57:313-370
31. Sharma RV, Bhalla RC (1988) Calcium and abnormal reactivity of vascular smooth muscle in hypertension. Cell Calcium 9:267-274
32. Furspan PB, Lamb FS, Ross PV, Webb RC, Bohr DF (1986) Calcium and vascular smooth muscle membrane in hypertension. Prog Clin Biol Res 219:225-243
33. Puscas L, Gilau L, Coltau M, Pasca R, Domuta G, Baican M, Hecht A (2000) Calcium channel blockers reduce blood pressure in part by inhibiting vascular smooth muscle carbonic anhydrase I. Cardiovasc Drugs Ther 14:523-528
34. Carvajal JA, Germain AM, Huidobro-Toro JP, Weiner CP (2000) Molecular mechanism of cGMP-mediated smooth muscle relaxation. J Cell Physiol 184:409-420
35. 2+-sensitivity and cGMP-independent effects of NO in vascular smooth muscle. Nitric Oxide 12:105-113
36. Wu DQ, Lee CH, Rhee SG, Simon MI (1992) Activation of phospholipase C by the alpha subunits of the Gq and G11 proteins in transfected Cos-7 cells. J Biol Chem 267:1811-1817
37. 2+)-independent protein kinase C activity is required for alpha1-adrenergic-receptor-mediated regulation of ribosomal protein S6 kinases in adult cardiomyocytes. Biochem J 373:603-611
38. Van Hove CE, Van der Donckt C, Herman AG, Bult H, Fransen P (2009) Vasodilator efficacy of nitric oxide depends on mechanisms of intracellular calcium mobilization in mouse aortic smooth muscle cells. Br J Pharmacol 158:920-930
39. Xu YC, Leung SW, Yeung DK, Hu LH, Chen GH, Che CM, Man RY (2007) Structure-activity relationships of flavonoids for vascular relaxation in porcine coronary artery. Phytochemistry 68:1179-1188
40. Si H, Liu D (2008) Genistein, a soy phytoestrogen, upregulates the expression of human endothelial nitric oxide synthase and lowers blood pressure in spontaneously hypertensive rats. J Nutr 138:297-304
41. Brossette T, Hundsdorfer C, Kroncke KD, Sies H, Stahl W (2011) Direct evidence that (-)-epicatechin increases nitric oxide levels in human endothelial cells. Eur J Nutr 50:595-599
42. Ramirez-Sanchez I, Maya L, Ceballos G, Villarreal F (2010) (-)-epicatechin activation of endothelial cell endothelial nitric oxide synthase, nitric oxide, and related signaling pathways. Hypertension 55:1398-1405
43. Shimoi K, Okada H, Furugori M, Goda T, Takase S, Suzuki M, Hara Y, Yamamoto H, Kinae N (1998) Intestinal absorption of luteolin and luteolin 7-O-beta-glucoside in rats and humans. FEBS Lett 438:220-224
44. Kim YH, Hwang JH, Noh JR, Gang GT, Kim do H, Son HY, Kwak TH, Shong M, Lee IK, Lee CH (2010) Activation of NAD(P)H:quinone oxidoreductase ameliorates spontaneous hypertension in an animal model via modulation of eNOS activity. Cardiovasc Res 91:519-527